Article

World Vaccine Congress 2010

The World Vaccine Congress Lyon is the premiere vaccine conference addressing all major vaccine markets.

The 12th annual World Vaccine Congress Lyon, organized by Terrapinn Ltd., opened on October 4, 2010, to provide solutions to today's biggest global challenges. Speakers, delegates, and exhibitors came from mainly European and North American regions to share their expertise, experience and services. The World Vaccine Congress Lyon is the premiere vaccine conference addressing all major vaccine markets, including influenza, HPV, pneumococcal, and meningococcal.

Sponsors and exhibitors present at the Congress include: Encorium, Millipore, Merck, GE Healthcare, Charles River labs, Eurocine, PAA Labs, SAFC, Fisher Clinical Services, Novozymes, Eurogentec, Vactia, Lonza, Luminex, ITS Innovation, AVIR Green Hills Biotech, Lipotek, Abd Serotec, Werum Software, Vibalogics, BioKinetic Europe and Accelovance.

Key themes for this year’s event include:

  • From R&D to S&E; a paradigm shift for vaccine R&D
  • Innovative vaccine differentiation and indication expansion
  • New vaccine franchise evolution
  • Penetrating emerging markets for revenue growth
  • Creative market-access strategies, market innovation and expansion
  • Capturing value and contributing to partnership success
  • Novel vaccine engineering, adjuvant development and antigen delivery advances
  • Accessing innovation: the increasing importance of externalisation
  • Advancing regulatory pathways and bridging the safety divide

To learn more about the 12th annual World Vaccine Congress Lyon and to download the conference brochure, click here.

A list of speakers who are scheduled to present at this year’s Congress is available here.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.